Skip to main content

TRILUMINATE Pivotal Trial

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about TRILUMINATE Pivotal Trial

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

Study of Treatment's Echocardiographic Mechanisms

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study of Treatment's Echocardiographic Mechanisms

MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

A Study of Lazertinib in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of Lazertinib in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial

Dexamethasone for Migraine - Dose Comparison

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Dexamethasone for Migraine - Dose Comparison

Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia

APAP +/- Oxycodone

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about APAP +/- Oxycodone

A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 216
  • Page 217
  • Page 218
  • Page 219
  • Page 220
  • Page 221
  • Page 222
  • Page 223
  • Page 224
  • …
  • Next page Next
  • Last page Last
Subscribe to